Organo Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Organo recent Real Value cannot be determined due to lack of data. The prevailing price of Organo is $0.0. Our model determines the value of Organo from analyzing the company fundamentals such as Return On Equity of 13.05, operating margin of 9.53 %, and Shares Owned By Insiders of 42.86 % as well as examining its technical indicators and probability of bankruptcy.
Organo Total Value Analysis
Organo is now forecasted to have takeover price of 4.22 B with market capitalization of 4.22 B, debt of 16.7 B, and cash on hands of 13.5 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Organo fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.22 B | 4.22 B | 16.7 B | 13.5 B |
Organo Investor Information
About 43.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 29th of September 2022. Based on the analysis of Organo's profitability, liquidity, and operating efficiency, Organo is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Organo Asset Utilization
One of the ways to look at asset utilization of Organo is to check how much profit was generated for every dollar of assets it reports. Organo operates its assets almost 5.71 pct., making $0.0571 for each dollar of assets held by the company. A positive asset utilization implies the company is slightly more effective with each dollar of assets it holds. Put it differently, asset utilization of Organo shows how effective it operates for each dollar spent on its assets.Organo Profitability Analysis
The company reported the revenue of 109.74 B. Net Income was 8.79 B with profit before overhead, payroll, taxes, and interest of 26.33 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Organo's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Organo and how it compares across the competition.
Organo Growth Indicators
Investing in growth stocks can be very risky. If the company such as Organo does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Earnings Quarterly Growth | 72.90% | |
| Revenue Growth | 18.90% | |
| Float Shares | 6.48M | |
| Earnings Growth | 73.10% |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Organo Pink Sheet
If you are still planning to invest in Organo check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Organo's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |